跳至主要内容
临床试验/NCT05091021
NCT05091021已完成不适用

Skeletal Effects of Chronic Night Shift (ACORN Study)

University of Colorado, Denver2 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2021年10月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
59
试验地点
2
主要终点
Difference in change of propeptide of type 1 procollagen (P1NP) over 1 year

研究概览

简要总结

The specific aim of this observational study is to characterize changes in bone turnover makers (BTMs), bone mineral density (BMD), and bone microarchitecture in a cohort of nurses during their first year of night compared to day shift work. The hypothesis is that night shift nurses will have poorer bone health indices at one year compared to day shift nurses.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy, nonpregnant adults 20-50 years old who recently (≤6 months) graduated from nursing school and were hired by University of Colorado Hospital for their first nursing position
  • For women to be eligible, they must be premenopausal, not breastfeeding, not pregnant with no plans to become pregnant during the year of observation and willing/able to maintain their current method of contraception use as detailed below.
  • Willing and able to travel to/from CU-AMC for study measurements at baseline and quarterly for one full year

排除标准

  • Non-nursing school related shift work 1 year prior to study. (note: many nursing students work as an Advanced Care Partner (ACP) or as a Student Nurse Extern (SNE) and these positions will not be considered exclusionary).
  • Current smokers at baseline (or within the previous year of study).
  • Individuals who are concurrently participating in another research protocol that would influence their safe participation in this study. For example, participants involved in a study that requires blood draws or ingestion of experimental medication as this would increase the risk of participation in our study and/or compromise study results.
  • Any clinically significant unstable medical or surgical condition within the last year (treated or untreated), including history of a clinically significant abnormality of the neurological system (including cognitive disorders or significant head injury) or any history of seizure (including febrile seizure-sleep loss has been used clinically to induce seizures in patients with epilepsy). Given the wide range of illnesses that are encountered in medical practice, it would not be possible to provide a comprehensive list of each and every disease that could serve as grounds for exclusion for the subject. However, the following is a list of illness categories that would certainly be grounds for exclusion: Connective Tissue and Joint Disorders; Neurologic/cognitive Disorders; Musculoskeletal Disorders; Immune Disorders; Chronobiologic Disorders; Cardiovascular Disorders; Respiratory Disorders; Kidney Disorders; Infectious Diseases; Hematopoietic Disorders; Neoplastic Diseases; and Endocrine and Metabolic Diseases.
  • Self-reported or newly diagnosed medical condition that is still being investigated or is not under good control, including those identified on screening labs such as:
  • o Out-of-range values measured on a blood sample such as glucose, TSH, creatinine or hemoglobin, that represent clinically significant abnormalities that may jeopardize safe participation or accuracy of outcome measures, at PI discretion
  • Any unstable psychiatric condition including but not limited to schizophrenic disorders and previously diagnosed personality disorders. Individuals with a history of anxiety or depression that has not required inpatient treatment and is well controlled without medication or on a stable medication dose will be permitted at the PI's discretion. Additionally, a personal history of limited prior counseling, psychotherapy (e.g., for adjustment reactions) will NOT be exclusionary.
  • Evaluation of Psychiatric/Psychological Suitability:
  • Inability to demonstrate a full understanding of the requirements and demands of the study.
  • Individuals who are unaware of specific psychiatric diagnoses who have a history of having been treated with antidepressants, neuroleptic medications or major tranquilizers will be excluded from study.
  • Individuals with any clinically significant sleep disorder; Diagnosis or symptoms of sleep disorders (history of significant parasomnia as an adult [night terrors, frequent sleep walking], insomnia, including but not limited to hypersomnias such as apnea, periodic limb movements, narcolepsy). Sleep disorders will be screened by self-report and physician interview including use of validated sleep questionnaires (PSQI, Epworth sleepiness scale, and Berlin sleep questionnaire for sleep apnea).
  • Individuals on medications known to affect bone turnover (e.g., glucocorticoids, osteoporosis medications);
  • Individuals with eGFR < 60 mL/min/1.73m2 as this is known to affect CTX measurements.
  • Symptoms of active illness (e.g., fever) at time of enrollment; note - participant may be studied at a later date if they have not yet started their clinical duties by that time

研究组 & 干预措施

University of Colorado Health New Nurses (Night Shift Workers)

Night shift work group nurses have greater than 50% of their shifts as night shifts.

University of Colorado Health New Nurses (Day Shift Workers)

Day shift work group nurses have greater than 50% of their shifts as day shifts.

结局指标

主要结局

Difference in change of propeptide of type 1 procollagen (P1NP) over 1 year

时间窗: From baseline up to 12 months

Difference in change of P1NP over 1 year between the two groups (night vs. day shift nurses), as measured via bone biomarker assays (immunodiagnostic systems, chemiluminescence, immunoassay)

次要结局

  • Between-group differences in the change in osteocalcin(From baseline up to 12 months)
  • Between-group differences in the change in CTX (C-telopeptide of type I collagen)(From baseline up to 12 months)
  • DXA-derived areal bone mineral density (aBMD) changes(From baseline up to 12 months)
  • Change in bone microarchitecture(From baseline up to 12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Skeletal Effects of Chronic Night Shift | 临床试验